A Novartis experimental drug in clinical trial aims to block liver cancer growth

A cellular computing error wreaks havoc on vision.

New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.